NIH/National Institute of Allergy and Infectious Diseases

Vaccination

Experimental COVID-19 vaccine safe, generates immune response

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy ...

Diseases, Conditions, Syndromes

New coronavirus stable for hours on surfaces: study

The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, according to a new study from National Institutes of Health, CDC, UCLA and Princeton University scientists ...

Diseases, Conditions, Syndromes

Remdesivir prevents MERS coronavirus disease in monkeys

The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), according to a new study from National Institutes of Health scientists. ...

Neuroscience

Scientists develop test for uncommon brain diseases

National Institutes of Health (NIH) scientists have developed an ultrasensitive new test to detect abnormal forms of the protein tau associated with uncommon types of neurodegenerative diseases called tauopathies. As they ...

HIV & AIDS

Drug reverses signs of liver disease in people living with HIV

Researchers at the National Institutes of Health and their colleagues at Massachusetts General Hospital (MGH) in Boston report that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) ...

Diseases, Conditions, Syndromes

Human antibody reveals hidden vulnerability in influenza virus

The ever-changing "head" of an influenza virus protein has an unexpected Achilles heel, report scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. ...

page 4 from 40